![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Takeda establishes new trading company and reinforces business structure in China
Takeda Pharmaceutical Company Limited ("Takeda") today announced the launch of a new trading company...
Potential new treatment for gastrointestinal cancers discovered
Researchers have identified a complex of proteins that promotes the growth of some types...
Gene therapy cocktail shows promise in long-term clinical trial for rare fatal brain disorder
Results of a clinical trial that began in 2001 show that a gene therapy...
New cell-based system can screen drug candidates for cardiac toxicity
A new stem cell-derived system for screening experimental drugs for cardiotoxicity could identify dangerous...
Novartis drug Signifor® gains FDA approval as the first medication to treat Cushing’s disease
Novartis announced that the US Food and Drug Administration (FDA) has approved Signifor® (pasireotide)...
New screening approach identified potential drug combos for difficult-to-treat melanomas
A novel approach to identifying potential anticancer drug combinations revealed that pairing cholesterol-reducing drugs...
Novel therapeutic agents provide hope for patients with hard-to-treat blood disorders
Encouraging safety and efficacy data on novel and emerging therapies presented at the 54th...
Clinical trial hits new target in war on breast cancer
Breast cancers are defined by their drivers - estrogen and progesterone receptors (ER and...
GSK welcomes the publication of the 2012 Access to Medicines Index
GSK welcomes the publication of the third Access to Medicines (ATM) Index, which measures...
Promising drug slows down advance of Parkinson’s disease and improves symptoms
Treating Parkinson's disease patients with the experimental drug GM1 ganglioside improved symptoms and slowed...